Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5374103 | 0.91 | CYP3A4 (0.42) | CYP3A4L3MBTL1 | |
| SCHEMBL4266447 | 0.86 | CYP3A4 (0.35) | CYP3A4L3MBTL1 | |
| SCHEMBL2324733 | 0.84 | — | — | |
| SCHEMBL4267114 | 0.84 | CYP3A4 (0.30) | CYP3A4L3MBTL1 | |
| SCHEMBL2328993 | 0.83 | — | — | |
| SCHEMBL2328463 | 0.82 | CYP3A4 (0.35) | CYP3A4L3MBTL1 | |
| SCHEMBL4279715 | 0.79 | CYP3A4 (0.33) | CYP3A4L3MBTL1 | |
| SCHEMBL6053372 | 0.78 | — | — | |
| SCHEMBL4278230 | 0.77 | — | — | |
| SCHEMBL2326355 | 0.77 | MAPT (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1987881-B1 | METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE | ASAHI KASEI CHEMICALS CORP (JP) | 2011-08-17 | — | — | EP | disclosed |
| US-7842828-B2 | Method for separating out and recovering dialkyltin dialkoxide | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-11-30 | — | — | US | disclosed |
| US-20100160662-A1 | Method for Separating Out and Recovering Dialkyltin Dialkoxide | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2010-06-24 | — | — | US | disclosed |
| EP-1987881-A1 | METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE | Asahi Kasei Chemicals Corporation (JP) | 2008-11-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160662-A1 | Method for Separating Out and Recovering Dialkyltin Dialkoxide | ALOX5, ALOX15B, ALOX15 | CYP3A4 796/4885L3MBTL1 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.